D-0473-2023 Class II Ongoing

Recalled by Noven Pharmaceuticals Inc — Miami, FL

FDA drug recall D-0473-2023 was initiated by Noven Pharmaceuticals Inc on Mar 10, 2023 and is designated Class II. Reason for recall: Defective Delivery System: Out of specification for shear. The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Mar 29, 2023
Initiation Date
Mar 10, 2023
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Daytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5555-3

Reason for recall

Defective Delivery System: Out of specification for shear.

Distribution pattern

US Nationwide

Code information

Lot#: 91474, 91959, Exp. 3/2023; 91958, Exp. 6/2023; 92478, Exp. 7/2023; 92479 & 92198, Exp. 8/2023; 92199, 93040, Exp. 9/2023; 93041, Exp. 10/2023.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0473-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0473-2023. Report a data issue: hello@regdatalab.com.